
Travis Neuscheler
Controller
Get their honest, personalized take on your startup.
Sign in to pitch Travis →At a glance
- Full Name
- Travis Neuscheler
- Title
- CFO and CCO
- Firm
- Northlane Capital Partners
- Firm Type
- Middle-market private equity firm
- Investment Stage
- Control-oriented private equity investments, including platform investments and add-ons
- Check Size
- $25 million to $150 million equity investments
- Target Company Profile
- North American middle-market companies with $50 million to $350 million enterprise value, $5 million to $30 million EBITDA, sustainable competitive advantages, attractive growth opportunities, strong financial performance, and experienced management teams
- Sector Focus
- Healthcare and business services
- Geographic Focus
- North America
- Location
- Bethesda, Maryland / Washington, D.C. area
Background
Travis Neuscheler is CFO and CCO of Northlane Capital Partners, a Bethesda-based middle-market private equity firm focused on healthcare and business services. Northlane’s team profile says he joined the firm in 2019 as Controller and now lists him as CFO and CCO.
Before Northlane, Neuscheler worked at Ernst & Young. His Northlane bio states that he was a Manager in EY’s Transaction Advisory Services practice and, before that, a Senior Associate in EY’s Financial Services Office audit practice.
Neuscheler earned a Master of Science in Accounting from the Carroll School of Management at Boston College and a Bachelor of Accountancy from The George Washington University School of Business. His role appears to be finance, compliance, and firm operations rather than front-line deal origination; public Northlane portfolio pages do not list him as a related deal team member on individual investments.
Investment Thesis & Focus
- Northlane states its core focus as: “We invest in leading niche companies in healthcare and business services.”
- The firm targets middle-market healthcare and business services companies in North America, generally with $50 million to $350 million enterprise value, $5 million to $30 million EBITDA, and $25 million to $150 million equity investment size.
- Target attributes include sustainable competitive advantages, attractive growth opportunities, a strong financial track record, and experienced management.
- Healthcare themes include aging population, increased medical-care utilization, cost containment, results-oriented medicine, and pharmaceutical R&D.
- Business services themes include outsourcing, digital transformation, data analytics, automation, technology-enabled services, and cost-containment-driven outsourcing.
- Northlane emphasizes value creation through organic growth, add-on acquisitions, and its executive network; the firm says it has completed more than 80 add-on transactions for portfolio companies.
- The firm buys from founders and smaller institutional investors and works with management teams and deal sources; it says: “We move swiftly and with conviction to acquire assets that fit our strategy.”
Notable Investments
- File & ServeXpress: Court technology platform serving courts, government agencies, law firms, and legal professionals; Northlane announced the investment in March 2026.
- Plus Delta Partners: Fundraising training and tools provider for higher education, healthcare organizations, and nonprofits; Northlane invested alongside management and founder Guy Hart in January 2025.
- United States Drug Testing Laboratories: Forensic toxicology laboratory testing for alcohol and substance use; Northlane invested in January 2025.
- Empower Community Care: Behavioral health enablement platform for evidence-based programs, training, consulting, and software; Northlane sold the company to NexPhase Capital in July 2025.
- The Difference Card: Healthcare cost-containment solutions provider; Northlane announced its sale in July 2025.
- Choice Financial Group: Acquisition-focused insurance agency providing property and casualty insurance and employee benefits services.
- Firma Clinical Research: Niche CRO providing clinical data management, biostatistics, remote visits, clinical operations, medical writing, and clinical-trial support.
- SAI MedPartners: Strategic insights and analytics consultancy serving pharmaceutical, biotechnology, and medical-device companies.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.